NCT00242788 IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure Status COMPLETED Phase PHASE1/PHASE2
NCT00242775 Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg Status COMPLETED Phase PHASE3
NCT00242762 ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer Status COMPLETED Phase PHASE2
NCT00242749 IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma Status COMPLETED Phase PHASE2
NCT00242736 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Status COMPLETED Phase PHASE4
NCT00242411 MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults Status COMPLETED Phase PHASE4
NCT00242372 GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin Status TERMINATED Phase PHASE3
NCT00242346 High Doses of Candesartan Cilexetil on the Reduction of Proteinuria Status COMPLETED Phase PHASE3
NCT00242320 Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119) Status COMPLETED Phase PHASE3
NCT00242307 Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05) Status COMPLETED Phase PHASE2/PHASE3
NCT00242294 Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06) Status COMPLETED Phase PHASE2/PHASE3
NCT00241553 Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Status COMPLETED Phase PHASE3
NCT00241540 Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Status COMPLETED Phase PHASE3
NCT00241527 Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Status COMPLETED Phase PHASE3
NCT00241514 Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Status COMPLETED Phase PHASE3
NCT00241501 Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients Status COMPLETED Phase PHASE3
NCT00241488 DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia Status COMPLETED Phase PHASE3
NCT00241475 Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy Status COMPLETED Phase PHASE2
NCT00241462 Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients Status TERMINATED Phase N/A
NCT00241449 A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer Status COMPLETED Phase PHASE3